1. 139 A retrospective review of lung cancer patients receiving whole brain radiotherapy treated at the Kent Oncology Centre (KOC) in 2014, audited against the QUARTZ trial. (January 2016) Authors: Hegarty, G.; Turner, J.Y.; Sevitt, T.; Burcombe, R.; Cominos, M.; Taylor, H.; Beesley, S.; Hadaki, M.; Shah, R.; Mikropoulos, C.; Hall, J. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 142P CODAK real-world study: Interim analysis of clinical outcomes in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (CRT) in the United Kingdom. (December 2022) Authors: Franks, K.; Ahmed, M.; Smith, D.; Shaw, P.H.; Banna, G.; Cominos, M.; Walther, J.; Talbot, T.; Taylor, P.; Blak, B.; Lindqvist, L.; Paul, S.K.; Vincent, D. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 64 Management of EGFR tyrosine kinase inhibitor associated skin toxicity: a single centre experience. (January 2016) Authors: Thomas, L.; Hadaki, M.; Sevitt, T.; Shah, R.; Burcombe, R.; Hall, J.; Taylor, H.; Beesley, S.; Cominos, M. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 66: Adjuvant chemotherapy dose delivery for completely resected NSCLC in a regional cancer centre: analysis of outcomes by age and comorbidity. (January 2015) Authors: Wood, S.; Li, R.; Beesley, S.; Brown, J.; Cominos, M.; Hall, J.; Sevitt, T.; Shah, R.; Taylor, H.; Burcombe, R. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 71: Audit of the epidermal growth factor tyrosine kinase (EGFR) and anaplastic lymphoma kinase (ALK) mutation request pathway in non-squamous non-small cell lung cancer (NSCLC) in Kent. (January 2015) Authors: Taylor, H.; Shah, R.; Mccormick, G.; Burcombe, R.; Beesley, S.; Cominos, M.; Hall, J.; Sevitt, T. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma – A comparison of the FLOT and 'MAGIC' regimens. (March 2022) Authors: Moore, Jonathan L.; Kumar, Sacheen; Santaolalla, Aida; Patel, Pranav H.; Kapiris, Matthaios; Van Hemelrijck, Mieke; Maisey, Nick; Hill, Mark; Lagergren, Jesper; Gossage, James A.; Kelly, Mark; Chaudry, Asif; Allum, William H.; Baker, Cara R.; Cunningham, David; Davies, Andrew R.; Jacques, A.; Gri... Journal: European journal of cancer Issue: Volume 163(2022) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SABR implementation at a regional cancer centre: first-year outcomes and challenges at the Kent Oncology Centre. (January 2019) Authors: Forner, S.; Cominos, M.; Brown, J.; Burcombe, R.; Hall, J.; Hadaki, M.; Brulinski, P.; Sevitt, T. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗